vs
Side-by-side financial comparison of DONEGAL GROUP INC (DGICA) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $236.0M, roughly 1.1× DONEGAL GROUP INC). DONEGAL GROUP INC runs the higher net margin — 4.9% vs 0.7%, a 4.2% gap on every dollar of revenue. On growth, DONEGAL GROUP INC posted the faster year-over-year revenue change (-3.7% vs -16.5%).
Donegal Group Inc. is a regional US insurance holding company offering personal and commercial property and casualty insurance products. It serves Mid-Atlantic, Midwest, and Southern US customers, delivering tailored coverage for individuals, families, and small to medium businesses.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
DGICA vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.0M | $270.8M |
| Net Profit | $11.5M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | — | -13.2% |
| Net Margin | 4.9% | 0.7% |
| Revenue YoY | -3.7% | -16.5% |
| Net Profit YoY | -54.3% | -83.6% |
| EPS (diluted) | — | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $236.0M | — | ||
| Q4 25 | $239.8M | $270.8M | ||
| Q3 25 | $245.9M | — | ||
| Q2 25 | $247.1M | $277.7M | ||
| Q1 25 | $245.2M | $324.5M | ||
| Q4 24 | $250.0M | — | ||
| Q3 24 | $251.7M | — | ||
| Q2 24 | $246.8M | $305.7M |
| Q1 26 | $11.5M | — | ||
| Q4 25 | $17.2M | $2.0M | ||
| Q3 25 | $20.1M | — | ||
| Q2 25 | $16.9M | $455.0M | ||
| Q1 25 | $25.2M | $11.9M | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $16.8M | — | ||
| Q2 24 | $4.2M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | -13.2% | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | 8.3% | -1.3% | ||
| Q1 25 | 12.7% | -5.0% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 2.0% | -9.0% |
| Q1 26 | 4.9% | — | ||
| Q4 25 | 7.2% | 0.7% | ||
| Q3 25 | 8.2% | — | ||
| Q2 25 | 6.8% | 163.8% | ||
| Q1 25 | 10.3% | 3.7% | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 1.7% | 8.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.01 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $649.1M | $1.2B |
| Total Assets | $2.4B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $649.1M | — | ||
| Q4 25 | $640.4M | $1.2B | ||
| Q3 25 | $627.4M | — | ||
| Q2 25 | $605.7M | $1.2B | ||
| Q1 25 | $584.7M | $759.9M | ||
| Q4 24 | $545.8M | — | ||
| Q3 24 | $513.4M | — | ||
| Q2 24 | $484.1M | $740.1M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $1.8B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | $1.8B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $70.2M | $8.2M | ||
| Q3 25 | $22.4M | — | ||
| Q2 25 | $12.1M | $-72.9M | ||
| Q1 25 | $25.7M | $40.3M | ||
| Q4 24 | $67.4M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $21.7M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.08× | 4.21× | ||
| Q3 25 | 1.11× | — | ||
| Q2 25 | 0.72× | -0.16× | ||
| Q1 25 | 1.02× | 3.38× | ||
| Q4 24 | 2.81× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 5.22× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
